Open Accessibility Menu
Hide

DAPA ACT HF-TIMI 68

Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

Objective

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction Who Have Been Stabilized During Hospitalization for Acute Heart Failure.

Study ID: NCT04363697

IRB Protocol Number

D1699C00004

Principal Investigator(s)

Jason Go, MD

Related Blogs